Predictors of occlusion, long-term outcomes, and safety in a cohort of 674 aneurysms treated with the Pipeline embolization device
Rawad Abbas(Thomas Jefferson University Hospital), Pascal Jabbour(Thomas Jefferson University Hospital), Mohamed M. Salem(Hospital of the University of Pennsylvania), Joshua Weinberg(The Ohio State University Wexner Medical Center), Georgios S. Sioutas(Virginia Commonwealth University), Jad El-Hajj(St. George's University), Clifford J. Yudkoff(Thomas Jefferson University Hospital), Stavropoula Tjoumakaris(Thomas Jefferson University Hospital), Kareem El Naamani(Thomas Jefferson University), Hekmat Zarzour(Thomas Jefferson University), Ahmad Sweid(University of Chicago), Robert H. Rosenwasser(Thomas Jefferson University), Nabeel Herial(Bruce Technologies (United States)), Abdelaziz Amllay(Yale University), Richard F. Schmidt(Thomas Jefferson University), M. Reid Gooch(Thomas Jefferson University Hospital), Abhijeet Sambangi(Thomas Jefferson University Hospital), Elias Atallah(Thomas Jefferson University Hospital), Jaime Dougherty(Thomas Jefferson University Hospital), Abdulaziz Alhussein(Thomas Jefferson University Hospital), Rouaida Kadhim A Al-Hussein(Thomas Jefferson University Hospital)
Cited by 16
Related Papers
International Retrospective Study of the Pipeline Embolization Device: A Multicenter Aneurysm Treatment Study
|American Journal of Neuroradiology|2014|568
Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association
|Stroke|2021|293
Endovascular robotic: feasibility and proof of principle for diagnostic cerebral angiography and carotid artery stenting
|Journal of NeuroInterventional Surgery|2020|83
Lower complication rates associated with transradial versus transfemoral flow diverting stent placement
|Journal of NeuroInterventional Surgery|2020|80